Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.882 USD | -0.43% | +19.87% | -5.43% |
May. 14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
May. 13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.43% | 32.8M | |
+19.04% | 84.52B | |
-27.57% | 72.21B | |
+4.65% | 27.74B | |
-7.91% | 17.97B | |
-0.46% | 17.46B | |
+3.65% | 15.82B | |
+7.06% | 13.55B | |
+6.59% | 13.31B | |
+69.25% | 12.5B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Transcript : Exagen Inc., Q4 2022 Earnings Call, Mar 20, 2023